Posts relating to PHE Priority 3: Protecting the country's health
In this blog post, we’ll explore how scientists are using organs grown in labs to help accelerate the development of new drugs, therapeutic medicines and vaccines.
As we release data showing a significant rise in travel-related infections like dengue and malaria, we speak to Colin Johnston, Senior Medical Entomologist at UKHSA, about his team’s work on invasive mosquito surveillance. Read on to find out how we …
Patients in British hospitals with serious, antibiotic-resistant gut infections have little in common with snakebite victims overseas. But when scientists made an unlikely connection in 2018, it led to trials for a potential new treatment for antibiotic-resistant infections. In this …
As we approach another winter season, UK Health Security Agency (UKHSA) is ramping up its comprehensive surveillance systems to monitor flu and other seasonal respiratory viruses. Here's an overview of how we're working to keep the nation informed and protected. …
As we approach winter, it’s time for people at risk to be booked in for their free flu jab. If you’re eligible, you need to know why it matters that you take up the offer. Flu is far more than …
A summary of who is eligible to receive the COVID-19 vaccine or autumn booster in 2024. Current vaccines provide good protection against severe disease and hospitalisation, with protection lasting for around 4 months.
As our world becomes increasingly interconnected and the climate changes, the UK faces challenges that we might associate with more exotic destinations. One such challenge is the potential introduction of invasive mosquito species, particularly the tiger mosquito (Aedes albopictus). This …
Doug Jenkinson was a Midlands GP for 37 years, during which time he made a special study of whooping cough and documented over 700 cases. The thing about whooping cough is that anyone can diagnose it once they have heard …
Antimicrobial resistance (AMR) occurs when medicines used to fight infections lose their effectiveness because the organisms they target – whether bacteria, fungi, viruses or parasites – have evolved or acquired adaptations to survive. In 2019, AMR was directly responsible for …
As we release our Commercial Strategy, I wanted to reflect on the ways in which we partner with industry to drive greater innovations and better health outcomes. One unintended consequence of the response to COVID-19 was the suppression of many …
